Lupin Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,167.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.70 per cent from ₹7,047.51 crore. This corresponds to a year-on-year *(YoY) growth of 24.27 per cent.
Operating Profit
Operating Profit stands at ₹1,835.28 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.61 per cent from ₹2,341.33 crore. This corresponds to a year-on-year *(YoY) growth of 35.36 per cent.
PBDT
PBDT stands at ₹1,835.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.03 per cent from ₹2,323.74 crore. This corresponds to a year-on-year *(YoY) growth of 36.66 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,522.04 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 24.16 per cent from ₹2,006.97 crore. This corresponds to a year-on-year *(YoY) growth of 42.08 per cent.
Net Profit
Net Profit stands at ₹1,180.51 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.50 per cent from ₹1,484.83 crore. This represents a 37.45 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Lupin Ltd News
Lupin Ltd Earnings
- YOY
- QOQ
Lupin Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lupin Ltd Research Reports
Lupin Ltd Financial Reports
Lupin Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 1.54% | 1.68% | 7.91% | 12.96% | 20.17% | 15.87% |
| Torrent Pharma. | 0.55% | 0.36% | 10.50% | 15.84% | 20.59% | 42.32% |
| Dr Reddy's Labs | 1.23% | 1.54% | 5.31% | 3.14% | 4.53% | 14.77% |
| Cipla | 1.00% | -1.64% | -0.39% | -11.48% | -14.00% | -9.32% |
| Zydus Lifesci. | 2.49% | -0.70% | 3.17% | -0.90% | -9.23% | 1.00% |
| Mankind Pharma | 1.23% | -1.14% | 7.89% | 1.68% | -13.83% | -2.30% |
| Aurobindo Pharma | 2.89% | 0.25% | 2.81% | 4.08% | 17.72% | 9.95% |
Company Info
Company Information
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal